Published in Medical Letter on the CDC and FDA, August 24th, 2008
"In the complex and fast-paced world of medicine, where patient safety is a primary concern, physicians need to be assured that they are using agents and the best possible safety profile. This is particularly important with agents that affect heart rhythm and may predispose patients to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.